Predictive value of GRACE risk scores for contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction before undergoing primary percutaneous coronary intervention

被引:25
|
作者
Liu, Yuan Hui [1 ]
Liu, Yong [2 ]
Tan, Ning [1 ,2 ]
Chen, Ji-yan [2 ]
Chen, Jin [2 ]
Chen, Shao-hui [2 ]
He, Yi-ting [2 ]
Ran, Peng [2 ]
Ye, Piao [2 ]
Li, Yun [2 ]
机构
[1] Southern Med Univ, Guangdong Gen Hosp, Dept Cardiol, Guangzhou 510515, Guangdong, Peoples R China
[2] Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Cardiovasc Inst, Dept Cardiol, Guangzhou 510100, Guangdong, Peoples R China
关键词
Percutaneous coronary intervention; Contrast-induced acute kidney injury; Acute myocardial infarction; C-REACTIVE PROTEIN; INDUCED NEPHROPATHY; N-ACETYLCYSTEINE; PRIMARY ANGIOPLASTY; RENAL HEMODYNAMICS; DYSFUNCTION; MORTALITY; IMPACT; ATORVASTATIN; PREVENTION;
D O I
10.1007/s11255-013-0598-5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives Contrast-induced acute kidney injury (CI-AKI) is a well-known serious complication of percutaneous coronary intervention (PCI) and may cause increased morbidity and mortality. We aim to identify the predictive value of Global Registry for Acute Coronary Events (GRACE) risk scores for CI-AKI in patients with ST-segment elevation myocardial infarction (STEMI) before primary PCI, allowing pre-procedural decisions regarding prevention therapy for CI-AKI. We enrolled 251 consecutive patients with STEMI undergoing primary PCI. Receiver operating characteristic curves were used to identify the optimal sensitivity for the observed range of GRACE risk scores. CI-AKI was defined as any of the following: absolute increase in serum creatinine (SCr) of a parts per thousand yen 0.3 or a parts per thousand yen 0.5 mg/dL within 48-72 h after contrast exposure, or a percentage increase in SCr level of a parts per thousand yen 50 %. Forty-three patients (17.1 %) developed CI-AKI0.3, 22 (8.8 %) CI-AKI0.5, and 19 (7.6 %) CI-AKI50. The GRACE quartiles were as follows: Q1 (< 136), Q2 (136-159), Q3 (159-180), and Q4 (> 180). Patients with high GRACE risk scores had higher risk for CI-AKI0.3, 0.5, and 50 (6.6, 6.6, 23.4, 31.7 %, respectively, p < 0.001; 1.6, 1.6, 9.4, 22.2 %, respectively, p < 0.001; and 3.3, 3.2, 9.4, 14.3 %, respectively, p = 0.009). ROC showed that a GRACE risk score > 160 was a fair discriminator for CI-AKI0.3, 0.5, and 50 (C statistic = 0.723, 0.788, 0.668, respectively). After adjusting for potential confounding predictors, GRACE risk score > 160 remained significantly associated with CI-AKI0.3 or 0.5 (OR 3.84; 95 % CI 1.61-9.17; p = 0.002, or OR 5.54; 95 % CI 1.42-21.66; p = 0.014), and high-sensitivity C-reactive protein (Hs-CRP) > 15.5 mg/L was a highly significant predictor of CI-AKI0.3, 0.5, and CI-AKI50. GRACE risk score (> 160) and post-procedural Hs-CRP > 15.5 mg/L are independent and significant predictors of CI-AKI in patients with STEMI before primary PCI.
引用
收藏
页码:417 / 426
页数:10
相关论文
共 50 条
  • [21] Practical Risk Stratification Score for Prediction of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention in Patients With Acute ST-Segment Elevation Myocardial Infarction
    Koowattanatianchai, Sukrisd
    Chantadansuwan, Thamarath
    Kaladee, Akaphol
    Phinyo, Phichayut
    Patumanond, Jayanton
    CARDIOLOGY RESEARCH, 2019, 10 (06) : 350 - 357
  • [22] Zwolle risk score predicts contrast induced acute kidney injury in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention
    Kul, S.
    Uyarel, H.
    Ertas, G.
    Turfan, M.
    Kucukdagli, O. T.
    Erdogan, E.
    Ergelen, M.
    Vatankulu, M. A.
    Asoglu, E.
    Guvenc, T. S.
    EUROPEAN HEART JOURNAL, 2013, 34 : 400 - 400
  • [23] Outcomes for Cancer Patients with Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
    Jacobs, Joshua A.
    Pickworth, Kerry
    Boudoulas, Konstantinos Dean
    Hinkley, Megan
    McLaughlin, Eric
    Blais, Danielle
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2019, 20 (08) : 711 - 715
  • [24] Female gender and contrast-induced nephropathy in primary percutaneous intervention for ST-segment elevation myocardial infarction
    Lucreziotti, Stefano
    Centola, Marco
    Salerno-Uriarte, Diego
    Ponticelli, Giorgio
    Battezzati, Pier Maria
    Castini, Diego
    Sponzilli, Carlo
    Lombardi, Federico
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 174 (01) : 37 - 42
  • [25] Postprocedure Anticoagulation in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
    Yan, Yan
    Gong, Wei
    Ma, Changsheng
    Wang, Xiao
    Smith, Sidney C., Jr.
    Fonarow, Gregg C.
    Morgan, Louise
    Liu, Jing
    Vicaut, Eric
    Zhao, Dong
    Montalescot, Gilles
    Nie, Shaoping
    JACC-CARDIOVASCULAR INTERVENTIONS, 2022, 15 (03) : 251 - 263
  • [26] Predictive value of objective nutritional scores for contrast-induced acute kidney injury in elderly patients undergoing percutaneous coronary intervention
    Lin, K.
    Chen, L.
    Han, C.
    Wang, S.
    Yu, H.
    Liu, D.
    Guo, Y.
    Zhu, P.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3407 - 3407
  • [28] The Predictive Value of Gamma-Glutamyl Transferase for Contrast Induced Nephropathy Risk Stratification of Patients Presenting with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
    Oksuz, F.
    Cay, S.
    Turak, O.
    Celik, E.
    Mendi, M. A.
    Cankurt, T.
    Kuyumcu, S.
    Canpolat, U.
    Colgecen, M.
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 113 (07): : S119 - S119
  • [29] Prevention of contrast induced-acute kidney injury using coenzyme Q10 in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
    Ahmadimoghaddam, Davoud
    Talebi, Seyed Saman
    Rahmani, Ayesheh
    Zamanirafe, Maryam
    Parvaneh, Erfan
    Ranjbar, Akram
    Poorolajal, Jalal
    Mehrpooya, Maryam
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 79 (10) : 1341 - 1356
  • [30] Impact of small and dense low-density lipoprotein (sd-LDL)on contrast-induced acute kidney injury in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
    Yuhan Li
    Kai Ma
    Guoqi Shen
    Di Zheng
    Yongli Xuan
    Wenhua Li
    International Urology and Nephrology, 2021, 53 : 2611 - 2617